RJA
ACLX

Raymond James & Associates’s Arcellx ACLX Stock Holding History

Raymond James & Associates’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$417K Buy
4,992
+78
+2% +$5.19K ﹤0.01% 3208
2024
Q2 		$271K Sell
4,914
-793
-14% -$43.1K ﹤0.01% 3432
2024
Q1 		$397K Buy
+5,707
New +$362K ﹤0.01% 3206
2022
Q3 		– Sell
-18,900
Closed -$342K – 3938
2022
Q2 		$342K Buy
+18,900
New +$244K ﹤0.01% 3147

Other funds holding ACLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Raymond James & Associates's ACLX Position: Q3 2024 in Review

Raymond James & Associates increased its Arcellx (ACLX) stake by 1.6% in Q3 2024, buying an estimated $5.19K and bringing the position to 4,992 shares worth $417K. The position accounts for ﹤0.01% of the portfolio, ranked #3208.

Raymond James & Associates first reported a position in ACLX in Q2 2022 and has held it in 4 quarters since. 186 funds tracked by Wall St. Rank hold ACLX as of Q3 2024.

  • Raymond James & Associates held 4,992 shares of Arcellx worth $417K as of Q3 2024.
  • Raymond James & Associates bought 78 Arcellx shares in Q3 2024, an estimated $5.19K.
  • Arcellx made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3208 holding.
  • Raymond James & Associates first reported a position in Arcellx in Q2 2022 and has held it in 4 quarters since.
  • 186 funds tracked by Wall St. Rank held Arcellx as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.